Trials / Unknown
UnknownNCT02915809
A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults
A Randomized, Double-Blind, Multicenter Study to Compare the Immunological Efficacy and Safety of GC3110B With GCFLU Quadrivalent Inj. Administered Intramuscularly in Healthy Adults
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 414 (estimated)
- Sponsor
- Green Cross Corporation · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate immunological efficacy and safety of GC3110B versus GCFLU Quadrivalent Inj. among healthy adults in 18 to 60 years of age.
Detailed description
Adults 18 to 60 years of age will be randomly assigned in a 1:1 ratio to receive either GC3110B or GCFLU Quadrivalent Inj.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | GC3110B vaccine | 0.5mL, Intramuscular |
| BIOLOGICAL | GCFLU Quadrivalent Inj. vaccine | 0.5mL, Intramuscular |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2016-12-01
- Completion
- 2017-05-01
- First posted
- 2016-09-27
- Last updated
- 2016-09-29
Source: ClinicalTrials.gov record NCT02915809. Inclusion in this directory is not an endorsement.